mestinon dragees
meda pharmaceuticals switzerland gmbh - pyridostigmini bromidum - dragees - pyridostigmini bromidum 60 mg, maydis amylum, magnesii stearas, amylum pregelificatum, povidonum k 30, silica colloidalis anhydrica, talcum, Überzug: acaciae gummi, paraffinum perliquidum, paraffinum solidum, oryzae amylum, saccharum 161,569 mg, talcum, e 172 (rubrum), e 172 (flavum) pro compresso obducto. - vagotonicum, antimyasthenicum - synthetika
mestinon tabletten
meda pharmaceuticals switzerland gmbh - pyridostigmini bromidum - tabletten - pyridostigmini bromidum 10 mg, maydis amylum, lactosum monohydricum 30 mg, silica colloidalis anhydrica, talcum, amylum pregelificatum, magnesii stearas pro compresso. - vagotonicum, antimyasthenicum - synthetika
ubretid tabletten
takeda pharma ag - distigmini bromidum - tabletten - distigmini bromidum 5 mg, excipiens pro compresso. - parasympathomimeticum - synthetika
robinul-neostigmina injektionslösung
sintetica sa - glycopyrronii bromidum, neostigmini metilsulfas - injektionslösung - glycopyrronii bromidum 0.5 mg, neostigmini metilsulfas 2.5 mg, dinatrii phosphas dodecahydricus, acidum citricum, natrii hydroxidum, aqua ad iniectabile ad solutionem pro 1 ml corresp. natrium 3 mg. - anticolinergico e inibitore della colinesterasi - synthetika
mestinon retard tabletten
meda pharmaceuticals switzerland gmbh - pyridostigmini bromidum - tabletten - pyridostigmini bromidum 180 mg, cera carnauba, silica colloidalis anhydrica, magnesii stearas, tricalcii phosphas, zeinum pro compresso. - vagotonicum, antimyasthenicum - synthetika
robinul-neostigmine 0,50 mg/ml - 2,50 mg/ml injektionslösung
eumedica pharmaceuticals - glycopyrroniumbromid; neostigmin metilsulfate - injektionslösung - 0,50 mg/ml - 2,50 mg/ml - glycopyrroniumbromid 0.5 mg/ml; neostigmin metilsulfate 2.5 mg/ml - glycopyrronium bromide
pyridostigmin hormosan 180 mg retardtabletten
hormosan pharma gesellschaft mit beschränkter haftung - geschäftsanschrift - (3068808) - retardtablette - 180 mg
prostigmin 0,5 mg/1 ml injektionslösung
meda pharmaceuticals switzerland gmbh - neostigmini metilsulfas - injektionslösung - neostigmini metilsulfas 0.5 mg, natrii chloridum, acidum hydrochloridum 25 per centum, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - cholinergicum, antimyasthenicum - synthetika
prostigmin 12,5 mg/5 ml injektionslösung
meda pharmaceuticals switzerland gmbh - neostigmini metilsulfas - injektionslösung - neostigmini metilsulfas 12.5 mg, natrii chloridum, conserv.: phenolum 20 mg, aqua ad iniectabile q.s. ad solutionem pro 5 ml. - cholinergicum, antimyasthenicum - synthetika
mestinon 60 mg überzogene tablette
mylan epd - pyridostigmine bromide - Überzogene tablette - 60 mg - pyridostigmine bromide 60 mg - pyridostigmine